Tech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack AttackThe Motley Fool • 07/31/20
Report: China-Linked Hackers Targeted Coronavirus Vaccine Developer ModernaThe Motley Fool • 07/30/20
Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To ComeInvestors Business Daily • 07/30/20
Moderna board member resigns to avoid conflict of interest during coronavirus vaccine trialCNBC • 07/30/20
Moderna board member resigns to prevent perception of conflict of interest in vaccine trialMarket Watch • 07/30/20
Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FTBenzinga • 07/29/20
Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)Business Wire • 07/28/20